342 related articles for article (PubMed ID: 17634847)
1. Evaluation of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot study.
Alexiou GA; Fotopoulos AD; Papadopoulos A; Kyritsis AP; Polyzoidis KS; Tsiouris S
Ann Nucl Med; 2007 Jul; 21(5):293-8. PubMed ID: 17634847
[TBL] [Abstract][Full Text] [Related]
2. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Tsekeris P; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Magn Reson Imaging; 2014 Sep; 32(7):854-9. PubMed ID: 24848292
[TBL] [Abstract][Full Text] [Related]
3. Correlation of glioma proliferation assessed by flow cytometry with (99m)Tc-Tetrofosmin SPECT uptake.
Alexiou GA; Tsiouris S; Vartholomatos G; Fotakopoulos G; Papadopoulos A; Kyritsis AP; Voulgaris S; Fotopoulos AD
Clin Neurol Neurosurg; 2009 Dec; 111(10):808-11. PubMed ID: 19726126
[TBL] [Abstract][Full Text] [Related]
4. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
5. Correlation of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT with tumour grade and Ki-67 immunohistochemistry in glioma.
Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
Clin Neurol Neurosurg; 2014 Jan; 116():41-5. PubMed ID: 24309151
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of SPECT/CT with a hybrid camera for the functional anatomical mapping of primary brain tumors by [Tc99m] tetrofosmin.
Filippi L; Schillaci O; Santoni R; Manni C; Danieli R; Simonetti G
Cancer Biother Radiopharm; 2006 Feb; 21(1):41-8. PubMed ID: 16480330
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparison of (99m)Tc-GH SPECT/CT and (18)F-FDOPA PET/CT for detection of recurrent glioma: a pilot study.
Karunanithi S; Bandopadhyaya GP; Sharma P; Kumar A; Singla S; Malhotra A; Gupta DK; Bal C
Clin Nucl Med; 2014 Feb; 39(2):e121-8. PubMed ID: 23579970
[TBL] [Abstract][Full Text] [Related]
8. The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme.
Alexiou GA; Tsiouris S; Kyritsis AP; Fotakopoulos G; Goussia A; Voulgaris S; Fotopoulos AD
J Nucl Med; 2010 Dec; 51(12):1923-6. PubMed ID: 21078797
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of meningioma aggressiveness by (99m)Tc-Tetrofosmin SPECT.
Alexiou GA; Vartholomatos G; Tsiouris S; Papadopoulos A; Kyritsis AP; Polyzoidis KS; Voulgaris S; Fotopoulos AD
Clin Neurol Neurosurg; 2008 Jul; 110(7):645-8. PubMed ID: 18471956
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of pediatric CNS malignancies with (99m)Tc-methoxyisobutylisonitrile SPECT.
Kirton A; Kloiber R; Rigel J; Wolff J
J Nucl Med; 2002 Nov; 43(11):1438-43. PubMed ID: 12411545
[TBL] [Abstract][Full Text] [Related]
12. Brain SPECT and perfusion MRI: do they provide complementary information about the tumour lesion and its grading?
Daboudi M; Papadaki E; Vakis A; Chlouverakis G; Makrakis D; Karageorgou D; Simos P; Koukouraki S
Clin Radiol; 2019 Aug; 74(8):652.e1-652.e9. PubMed ID: 31164195
[TBL] [Abstract][Full Text] [Related]
13. Intracranial tumors after radiation therapy: role of 99mTc-tetrofosmin SPECT/CT with a hybrid camera.
Filippi L; Santoni R; Nicolì P; Danieli R; Schillaci O
Cancer Biother Radiopharm; 2009 Apr; 24(2):229-35. PubMed ID: 19409045
[TBL] [Abstract][Full Text] [Related]
14. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.
Kao CH; Tsai SC; Wang JJ; Ho YJ; Yen RF; Ho ST
Cancer; 2001 Jul; 92(2):434-9. PubMed ID: 11466699
[TBL] [Abstract][Full Text] [Related]
15. Detection of cervical lymph node metastases in nasopharyngeal carcinomas: comparison with technetium-99m tetrofosmin single photon emission computed tomography and with magnetic resonance imaging.
Tai CJ; Liu FY; Liang JA; Yang SN; Tsai MH; Kao CH
Anticancer Res; 2003; 23(1B):719-22. PubMed ID: 12680173
[TBL] [Abstract][Full Text] [Related]
16. Characterization of intracranial space-occupying lesions by ⁹⁹(m)Tc-Tetrofosmin SPECT.
Fotopoulos AD; Kyritsis AP; Tsiouris S; Al-Boucharali J; Papadopoulos A; Voulgaris S; Alexiou GA
J Neurooncol; 2011 Jan; 101(1):83-9. PubMed ID: 20496160
[TBL] [Abstract][Full Text] [Related]
17. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
[TBL] [Abstract][Full Text] [Related]
18. Imaging of Integrin α
Song YS; Park HS; Lee BC; Jung JH; Lee HY; Kim SE
Cancer Biother Radiopharm; 2017 Oct; 32(8):288-296. PubMed ID: 29053416
[TBL] [Abstract][Full Text] [Related]
19. [Importance of cerebral tomoscintigraphy using technetium-labeled sestamibi in the differential diagnosis of current tumor vs. radiation necrosis in subtentorial glial tumors in the adult].
Lamy-Lhullier C; Dubois F; Blond S; Lecouffe P; Steinling M
Neurochirurgie; 1999 May; 45(2):110-7. PubMed ID: 10448650
[TBL] [Abstract][Full Text] [Related]
20. Detection of recurrence in glioma: a comparative prospective study between Tc-99m GHA SPECT and F-18 FDG PET/CT.
Santra A; Kumar R; Sharma P; Bal C; Julka PK; Malhotra A
Clin Nucl Med; 2011 Aug; 36(8):650-5. PubMed ID: 21716014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
